Skip to main content

Advertisement

Log in

Transdermal Delivery of Macromolecules Using Solid-State Biodegradable Microstructures

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

ABSTRACT

Purpose

The purpose of this work is to demonstrate the feasibility of using a proprietary technology called MicroCor™, based on solid-state, biodegradable microstructures (SSBMS), for transdermal delivery of macromolecules.

Methods

The proteins FITC-BSA (66 kDa) and recombinant protective antigen (rPA; 83 kDa) were incorporated into SSBMS arrays using a mold-based, liquid formulation casting and drying process. Arrays were applied to the skin with a custom applicator and then inspected to assess the extent of microstructure dissolution. In vitro FITC-BSA delivery to human cadaver skin was visualized using light and fluorescence microscopy and quantified by extracting and measuring the fluorescently labeled protein. rPA-containing SSBMS arrays were applied in vivo to Sprague-Dawley rats. The resulting serum IgG response was measured by ELISA and compared with responses elicited from intramuscular (IM) and intradermal (ID) routes of administration.

Results

FITC-BSA and rPA SSBMS arrays successfully penetrated the skin. Microstructure dissolution was observed over >95% of the array area and >75% of the microstructure length. FITC-BSA delivery correlated with protein content in the formulations. Antibody titers after transdermal delivery of rPA were comparable or higher than IM and ID titers.

Conclusions

Transdermal delivery of macromolecules can be conveniently and effectively accomplished using the MicroCor technology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

SSBMS:

solid-state biodegradable microstructures

FITC-BSA:

fluorescein isothiocyanate—bovine serum albumin

rPA:

recombinant protective antigen (ex. Bacillus anthracis)

ID:

intradermal

IM:

intramuscular

IgG:

immunoglobulin G

PET:

polyethylene terephthalate

REFERENCES

  1. Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev. 2004;56:581–7.

    Article  CAS  PubMed  Google Scholar 

  2. McAllister DV, Wang PM, Davis SP, Park JH, Canatella PJ, Allen MG, et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies. Proc Natl Acad Sci U S A. 2003;100:13755–60.

    Article  CAS  PubMed  Google Scholar 

  3. Matriano JA, Cormier M, Johnson J, Young WA, Buttery M, Nyam K, et al. Macroflux microprojection array patch technology: A new and efficient approach for intracutaneous immunization. Pharm Res. 2002;19:63–70.

    Article  CAS  PubMed  Google Scholar 

  4. Wang PM, Cornwell M, Hill J, Prausnitz MR. Precise microinjection into skin using hollow microneedles. J Invest Dermatol. 2006;126:1080–7.

    Article  CAS  PubMed  Google Scholar 

  5. Xie Y, Xu B, Gao Y. Controlled transdermal delivery of model drug compounds by MEMS microneedle array. Nanomedicine. 2005;1:184–90.

    CAS  PubMed  Google Scholar 

  6. Teo MA, Shearwood C, Ng KC, Lu J, Moochhala S. In vitro and in vivo characterization of MEMS microneedles. Biomed Microdevices. 2005;7:47–52.

    Article  PubMed  Google Scholar 

  7. Rajaraman S, Henderson HT, Rajaraman S, Henderson HT. A unique fabrication approach for microneedles using coherent porous silicon technology. Sens Actuators B Chem. 2005;105:443–8.

    Article  Google Scholar 

  8. Zahn JD, Deshmukh A, Pisano AP, Liepmann D. Continuous on-chip micropumping for microneedle enhanced drug delivery. Biomed Microdevices. 2004;6:183–90.

    Article  CAS  PubMed  Google Scholar 

  9. Draize JH. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;83:377–90.

    Google Scholar 

  10. Little SF, Ivins BE, Fellows PF, Pitt ML, Norris SL, Andrews GP. Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine. Vaccine. 2004;22:422–30.

    Article  CAS  PubMed  Google Scholar 

  11. Henderson EA, Louie TJ, Ramotar K, Ledgerwood D, Hope KM, Kennedy A. Comparison of higher-dose intradermal hepatitis B vaccination to standard intramuscular vaccination of healthcare workers. Infect Control Hosp Epidemiol. 2000;21:264–9.

    Article  CAS  PubMed  Google Scholar 

  12. Alarcon JB, Hartley AW, Harvey NG, Mikszta JA. Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clin Vaccine Immunol. 2007;14:375–81.

    Article  CAS  PubMed  Google Scholar 

  13. Belshe RB, Newman FK, Wilkins K, Graham IL, Babusis E, Ewell M, et al. Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine. 2007;25:6755–63.

    Article  CAS  PubMed  Google Scholar 

Download references

ACKNOWLEDGMENTS

The authors would like to acknowledge Appala Sagi, Danir Bairamov, Mikhail Shapiro, Creag Trautman, and Wade Worsham of Corium International, Inc. for fabrication of the SSBMS arrays and design of the custom impactor device. The authors would also like to gratefully acknowledge Raymond Daynes of the University of Utah for helpful discussions and technical assistance with executing the immunization studies.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gary W. Cleary.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wendorf, J.R., Ghartey-Tagoe, E.B., Williams, S.C. et al. Transdermal Delivery of Macromolecules Using Solid-State Biodegradable Microstructures. Pharm Res 28, 22–30 (2011). https://doi.org/10.1007/s11095-010-0174-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-010-0174-y

KEY WORDS

Navigation